Support from readers like you keeps The Journal open.
You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.
If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.
The high level isolation apparatus in the High Secure Infectious Disease Unit at The Royal Free Hospital, Hampstead, London. PA Wire / Press Association Images
PA Wire / Press Association Images / Press Association Images
THE EXPERIMENTAL DRUG that was given to two Americans infected with Ebola was also given to a British health worker who is currently being treated in a hospital in London.
There is no proven cure for Ebola, which has killed more than 1,400 people already.
However, the two US aid workers treated with the new drug ZMapp recovered which has raised hopes.
Som what are the main drugs used to tackle the Ebola virus and how are the people infected treated?
Here are the facts.
No licensed drug exists for treating Ebola. Several prototypes are in the pipeline, one of which has been fast-tracked for use in the outbreak, although whether it works is unknown.
According to University of Oxford epidemiologist Oliver Brady, up to 30,000 people would have required drugs, either to combat or prevent infection, as of August 20.
Senior Matron Breda Athan demonstrates the use of a high level isolation apparatus. Jonathan Brady
Jonathan Brady
What is the new experimental drug, ZMapp?
ZMapp is a cocktail of three antibodies that cling to the virus and inhibit its reproduction, developed by Mapp Biopharmaceutical Inc. of San Diego, California, partly in conjunction with the US Army.
It has been tested successfully on lab monkeys but not evaluated on humans.
After the World Health Organisation said on August 12 it was ethical to use experimental treatment in the crisis, ZMapp was given to seven infected frontline workers.
Who has been given ZMapp?
Two American doctors have recovered; a Liberian doctor and a Spanish priest have died; and a doctor and a nurse, both Liberian, and a British nurse, who has been flown to London from Sierra Leone, are still in treatment.
Where did this drug come from?
Stocks of ZMapp, which is derived from tobacco leaves and is hard to produce on a large scale, are exhausted, the company said on August 12.
It is likely to take several more months “to get even a modest amount,” according to Anthony Fauci, director of the US National Institute for Allergy and Infectious Diseases (NIAID).
Advertisement
People gather as the await a truck with food stuff from the World Food Programme. AP / Press Association Images
AP / Press Association Images / Press Association Images
What other drugs are there?
TKM-Ebola: This drug is under development by Tekmira Pharmaceuticals Corp. of Vancouver, Canada, under a €105 million contract with the Pentagon.
The drug, using a technique called RNA interference, is designed to throw a genetic switch causing the death of cells infected by the virus.
Tests on a small group of monkeys have shown it provides 100 percent protection against an otherwise lethal dose of the virus.
It is currently in a Phase I trial, the first step in the three-phase test process. In this phase, a drug is evaluated on healthy non-infected humans to see whether it is safe.
Further phases test it for safety and effectiveness.
Tekmira said on August 14 that it was in contact with government agencies, NGOs and the WHO “on the potential use” of TKM-Ebola in west Africa.
Anti-viral drugs: Several proposed treatments for mitigating Ebola started out as drugs to inhibit replication of the influenza virus.
They include Avigan, a Japanese anti-flu tablet drug developed by Fujifilm Holdings Corp. that was approved in Japan on March 24 and is currently undergoing clinical trials in the United States. Japan said on August 25 it is ready to ship the drug to Ebola-hit areas if the WHO requests.
But it is unclear whether Avigan — lab name T-705 — will work on Ebola, which is part of a different viral family called filoviruses. No tests of T-705 have been done on Ebola-infected lab animals or humans.
A health worker is sprayed with disinfectant a prevention against the Ebola virus. AP / Press Association Images
AP / Press Association Images / Press Association Images
Vaccines:There are two main candidates, but both face extensive trials and neither is likely to be available before 2015 even if they are fast-tracked.
The British company GlaxoSmithKline (GSK) says a prototype vaccine may enter Phase I clinical trials among a small group of human volunteers “later this year.”
The formula comprises an adenovirus — a virus group best known for causing the common cold — into which two Ebola genes have been slotted.
The virus penetrates a cell and delivers its payload, which produces a protein that triggers an immune response to recognise and destroy an invading virus.
The adenovirus is designed not to replicate further, thus preventing any spread of the Ebola genes.
The other is a vaccine by Johnson & Johnson subsidiary Crucell, designed to combat Ebola and its cousin filovirus the Marburg virus.
Tests on monkeys found the formula to be completely protective in a single dose.
A Phase I trial, launched in 2006 with 32 volunteers, found the drug was safe. Another Phase I trial, with the drug tweaked to widen protection against the spectrum of viral strains, is planned for late 2015 or early 2016.
Trade war fears as Donald Trump imposes tariffs on Canada, Mexico and China
25 mins ago
4.2k
16
Israel
Israel expands raids and airstrikes in West Bank, blocking exits of refugee camp
15 mins ago
528
Jet Rescue Air Ambulance
All six people on medical transport plane died in crash, Mexico’s president says
Updated
16 hrs ago
92.4k
147
Your Cookies. Your Choice.
Cookies help provide our news service while also enabling the advertising needed to fund this work.
We categorise cookies as Necessary, Performance (used to analyse the site performance) and Targeting (used to target advertising which helps us keep this service free).
We and our 141 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting Accept All enables tracking technologies to support the purposes shown under we and our partners process data to provide. If trackers are disabled, some content and ads you see may not be as relevant to you. You can resurface this menu to change your choices or withdraw consent at any time by clicking the Cookie Preferences link on the bottom of the webpage .Your choices will have effect within our Website. For more details, refer to our Privacy Policy.
We and our vendors process data for the following purposes:
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content measurement, audience research and services development.
Cookies Preference Centre
We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent. You may exercise your right to consent, based on a specific purpose below or at a partner level in the link under each purpose. Some vendors may process your data based on their legitimate interests, which does not require your consent. You cannot object to tracking technologies placed to ensure security, prevent fraud, fix errors, or deliver and present advertising and content, and precise geolocation data and active scanning of device characteristics for identification may be used to support this purpose. This exception does not apply to targeted advertising. These choices will be signaled to our vendors participating in the Transparency and Consent Framework.
Manage Consent Preferences
Necessary Cookies
Always Active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then these services may not function properly.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not be able to monitor our performance.
Store and/or access information on a device 96 partners can use this purpose
Cookies, device or similar online identifiers (e.g. login-based identifiers, randomly assigned identifiers, network based identifiers) together with other information (e.g. browser type and information, language, screen size, supported technologies etc.) can be stored or read on your device to recognise it each time it connects to an app or to a website, for one or several of the purposes presented here.
Personalised advertising and content, advertising and content measurement, audience research and services development 126 partners can use this purpose
Use limited data to select advertising 96 partners can use this purpose
Advertising presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type or which content you are (or have been) interacting with (for example, to limit the number of times an ad is presented to you).
Create profiles for personalised advertising 72 partners can use this purpose
Information about your activity on this service (such as forms you submit, content you look at) can be stored and combined with other information about you (for example, information from your previous activity on this service and other websites or apps) or similar users. This is then used to build or improve a profile about you (that might include possible interests and personal aspects). Your profile can be used (also later) to present advertising that appears more relevant based on your possible interests by this and other entities.
Use profiles to select personalised advertising 71 partners can use this purpose
Advertising presented to you on this service can be based on your advertising profiles, which can reflect your activity on this service or other websites or apps (like the forms you submit, content you look at), possible interests and personal aspects.
Create profiles to personalise content 35 partners can use this purpose
Information about your activity on this service (for instance, forms you submit, non-advertising content you look at) can be stored and combined with other information about you (such as your previous activity on this service or other websites or apps) or similar users. This is then used to build or improve a profile about you (which might for example include possible interests and personal aspects). Your profile can be used (also later) to present content that appears more relevant based on your possible interests, such as by adapting the order in which content is shown to you, so that it is even easier for you to find content that matches your interests.
Use profiles to select personalised content 31 partners can use this purpose
Content presented to you on this service can be based on your content personalisation profiles, which can reflect your activity on this or other services (for instance, the forms you submit, content you look at), possible interests and personal aspects. This can for example be used to adapt the order in which content is shown to you, so that it is even easier for you to find (non-advertising) content that matches your interests.
Measure advertising performance 118 partners can use this purpose
Information regarding which advertising is presented to you and how you interact with it can be used to determine how well an advert has worked for you or other users and whether the goals of the advertising were reached. For instance, whether you saw an ad, whether you clicked on it, whether it led you to buy a product or visit a website, etc. This is very helpful to understand the relevance of advertising campaigns.
Measure content performance 58 partners can use this purpose
Information regarding which content is presented to you and how you interact with it can be used to determine whether the (non-advertising) content e.g. reached its intended audience and matched your interests. For instance, whether you read an article, watch a video, listen to a podcast or look at a product description, how long you spent on this service and the web pages you visit etc. This is very helpful to understand the relevance of (non-advertising) content that is shown to you.
Understand audiences through statistics or combinations of data from different sources 69 partners can use this purpose
Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics data) regarding your interactions and those of other users with advertising or (non-advertising) content to identify common characteristics (for instance, to determine which target audiences are more receptive to an ad campaign or to certain contents).
Develop and improve services 76 partners can use this purpose
Information about your activity on this service, such as your interaction with ads or content, can be very helpful to improve products and services and to build new products and services based on user interactions, the type of audience, etc. This specific purpose does not include the development or improvement of user profiles and identifiers.
Use limited data to select content 36 partners can use this purpose
Content presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type, or which content you are (or have been) interacting with (for example, to limit the number of times a video or an article is presented to you).
Use precise geolocation data 41 partners can use this special feature
With your acceptance, your precise location (within a radius of less than 500 metres) may be used in support of the purposes explained in this notice.
Actively scan device characteristics for identification 23 partners can use this special feature
With your acceptance, certain characteristics specific to your device might be requested and used to distinguish it from other devices (such as the installed fonts or plugins, the resolution of your screen) in support of the purposes explained in this notice.
Ensure security, prevent and detect fraud, and fix errors 78 partners can use this special purpose
Always Active
Your data can be used to monitor for and prevent unusual and possibly fraudulent activity (for example, regarding advertising, ad clicks by bots), and ensure systems and processes work properly and securely. It can also be used to correct any problems you, the publisher or the advertiser may encounter in the delivery of content and ads and in your interaction with them.
Deliver and present advertising and content 88 partners can use this special purpose
Always Active
Certain information (like an IP address or device capabilities) is used to ensure the technical compatibility of the content or advertising, and to facilitate the transmission of the content or ad to your device.
Match and combine data from other data sources 64 partners can use this feature
Always Active
Information about your activity on this service may be matched and combined with other information relating to you and originating from various sources (for instance your activity on a separate online service, your use of a loyalty card in-store, or your answers to a survey), in support of the purposes explained in this notice.
Link different devices 46 partners can use this feature
Always Active
In support of the purposes explained in this notice, your device might be considered as likely linked to other devices that belong to you or your household (for instance because you are logged in to the same service on both your phone and your computer, or because you may use the same Internet connection on both devices).
Identify devices based on information transmitted automatically 76 partners can use this feature
Always Active
Your device might be distinguished from other devices based on information it automatically sends when accessing the Internet (for instance, the IP address of your Internet connection or the type of browser you are using) in support of the purposes exposed in this notice.
Save and communicate privacy choices 55 partners can use this special purpose
Always Active
The choices you make regarding the purposes and entities listed in this notice are saved and made available to those entities in the form of digital signals (such as a string of characters). This is necessary in order to enable both this service and those entities to respect such choices.
have your say